Legal Representation
Attorney
Harold Milstein
USPTO Deadlines
Next Deadline
115 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
November 02, 2025
Extension Available
Until May 02, 2024
Application History
28 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 30, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Apr 23, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 23, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED |
Apr 22, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 22, 2025 | EXT4 | S | SOU EXTENSION 4 FILED |
Oct 3, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
Oct 3, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 3, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
Oct 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
May 2, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
May 1, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
May 1, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
May 1, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 6, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 4, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
Oct 4, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
Oct 4, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 2, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 7, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 7, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Feb 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jan 31, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Apr 15, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Apr 15, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Apr 15, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Apr 5, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 4, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and therapeutic biological products in the nature of living cells for use in treating hearing/auditory conditions and disorders; pharmaceutical preparations and therapeutic biological products in the nature of living cells for use in treating conductive hearing loss, sensorineural hearing loss, central hearing loss, mixed hearing loss, auditory neuropathy spectrum disorder and central auditory processing disorder and other hearing/auditory conditions and disorders
Classification
International Classes
005